Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 67 clinical trials
Featured trial
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Proof of Concept Study of Vascular Endothelial Growth Factor (VEGF)-B Blockade with the Monoclonal Antibody CSL346 in Subjects with Diabetic Kidney Disease

This is a prospective, multicenter, randomized, double-blind, placebo-controlled, proof of concept study to investigate the efficacy, safety, tolerability, and pharmacokinetics (PK) of repeat doses of CSL346 in 100 subjects with DKD and albuminuria receiving standard of care treatment.

  • 30 views
  • 12 Oct, 2021
  • 1 location
Featured trial
RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies

RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies

  • 218 views
  • 25 Mar, 2021
  • 1 location
Featured trial
  • 177 views
  • 23 Nov, 2020
  • 1 location
Featured trial
  • 1061 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Clinical Study Protocol Abbvie M11-352

Clinical Study Protocol Abbvie M11-352

  • 332 views
  • 25 Mar, 2021
  • 1 location
Efficacy of Dapagliflozin in Diabetes Associated Peripheral Neuropathy (DINE)

Diabetic peripheral neuropathy(DPN) is a length dependent axonal neuropathy that affects at least 50% of patients with diabetes mellitus. DPN is often asymptomatic during the early stages of diabetes ,however, once symptoms and overt deficits have developed, it cannot be reversed. Early diagnosis of neuropathy is important because early diagnosis …

  • 0 views
  • 15 Jun, 2022
  • 1 location
Pentoxifylline in Diabetic Kidney Disease (PTXRx)

kidneys from damage due to diabetes and other diseases. "Pentoxifylline in Diabetic Kidney Disease" is a study to bee conducted in 40 VA hospitals across the nation to determine definitively whether or

diabetes
pentoxifylline
nephropathy
diabetic nephropathy
  • 42 views
  • 20 Jun, 2022
  • 16 locations
A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects With Diabetic Kidney Disease

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease

nephropathy
diabetic nephropathy
  • 456 views
  • 20 Aug, 2022
  • 75 locations
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Proof of Concept Study of Vascular Endothelial Growth Factor (VEGF)-B Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease

kidney disease (DKD) and albuminuria receiving standard of care treatment.

diabetes
type 2 diabetes mellitus
hemoglobin a1c
vascular endothelial growth factor
  • 36 views
  • 19 Sep, 2022
  • 31 locations
Atrasentan in Patients With Proteinuric Glomerular Diseases (AFFINITY)

The AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease who are at risk of progressive loss of renal function.

nephropathy
diabetes
renal function
kidney function tests
sglt2
  • 31 views
  • 17 Jun, 2022
  • 36 locations